Hematology Hospital of Chinese Academy of Medical Sciences
Hematology Hospital of Chinese Academy of Medical Sciences
Tianjin, Tianjin Municipality, China2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CD5 CART for the Treatment of Relapsed and Refractory CD5 Hematological Tumors | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence | Recruiting | Not applicable | 2026-06-30 | NCT07234110 | |
| A Phase II Study Evaluating the Efficacy and Safety of ABSK021 (Pimicotinib)) in the Treatment of cGvHD Chronic Graft Versus Host Disease (cGvHD) | cGvHD | Enrolling by invitation | Phase 2 | 2024-08-12 | NCT06186804 |